Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name sEphB4-HSA
Trade Name
Drug Descriptions

sEphB4-HSA is a fusion protein that consists of the extracellular domain of human ephrin type-B receptor 4 (EphB4) and human serum albumin (HSA), which acts as a decoy to inhibit EphB4 signaling, leading to inhibition of tumor cell growth (PMID: 23721559, PMID: 25148033, PMID: 27941840).

DrugClasses EPHB4 Inhibitor 6
CAS Registry Number NA
NCIT ID C102569


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Bevacizumab + sEphB4-HSA Bevacizumab sEphB4-HSA 0 0
Cetuximab + sEphB4-HSA Cetuximab sEphB4-HSA 0 1
Cytarabine + sEphB4-HSA Cytarabine sEphB4-HSA 0 1
Paclitaxel + sEphB4-HSA Paclitaxel sEphB4-HSA 0 0
Pembrolizumab + sEphB4-HSA Pembrolizumab sEphB4-HSA 0 3
sEphB4-HSA sEphB4-HSA 0 3
sEphB4-HSA + Vincristine sulfate liposome Vincristine sulfate liposome sEphB4-HSA 0 1

Additional content available in CKB BOOST